vs

Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and AgEagle Aerial Systems Inc. (UAVS). Click either name above to swap in a different company.

AgEagle Aerial Systems Inc. is the larger business by last-quarter revenue ($2.0M vs $1.1M, roughly 1.7× Insight Molecular Diagnostics Inc.). AgEagle Aerial Systems Inc. runs the higher net margin — -132.7% vs -2015.4%, a 1882.6% gap on every dollar of revenue. On growth, Insight Molecular Diagnostics Inc. posted the faster year-over-year revenue change (-23.4% vs -40.0%). AgEagle Aerial Systems Inc. produced more free cash flow last quarter ($-3.3M vs $-7.0M). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs -17.9%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Elbit Systems Ltd. is an Israel-based international military technology company and defense contractor. Founded in 1966 by Elron, Elbit Systems is the primary provider of the Israeli military's land-based equipment and unmanned aerial vehicles. It is an important company within the defense industry of Israel.

IMDX vs UAVS — Head-to-Head

Bigger by revenue
UAVS
UAVS
1.7× larger
UAVS
$2.0M
$1.1M
IMDX
Growing faster (revenue YoY)
IMDX
IMDX
+16.7% gap
IMDX
-23.4%
-40.0%
UAVS
Higher net margin
UAVS
UAVS
1882.6% more per $
UAVS
-132.7%
-2015.4%
IMDX
More free cash flow
UAVS
UAVS
$3.7M more FCF
UAVS
$-3.3M
$-7.0M
IMDX
Faster 2-yr revenue CAGR
IMDX
IMDX
Annualised
IMDX
154.4%
-17.9%
UAVS

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
IMDX
IMDX
UAVS
UAVS
Revenue
$1.1M
$2.0M
Net Profit
$-23.0M
$-2.6M
Gross Margin
42.5%
38.5%
Operating Margin
-2057.5%
-160.1%
Net Margin
-2015.4%
-132.7%
Revenue YoY
-23.4%
-40.0%
Net Profit YoY
31.5%
24.4%
EPS (diluted)
$-0.75
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMDX
IMDX
UAVS
UAVS
Q4 25
$1.1M
Q3 25
$260.0K
$2.0M
Q2 25
$518.0K
$4.2M
Q1 25
$2.1M
$3.6M
Q4 24
$1.5M
$2.8M
Q3 24
$115.0K
$3.3M
Q2 24
$104.0K
$3.4M
Q1 24
$176.0K
$3.9M
Net Profit
IMDX
IMDX
UAVS
UAVS
Q4 25
$-23.0M
Q3 25
$-10.9M
$-2.6M
Q2 25
$-9.7M
$-1.3M
Q1 25
$-6.7M
$7.1M
Q4 24
$-33.5M
$-22.3M
Q3 24
$-13.5M
$-3.5M
Q2 24
$-4.5M
$-2.9M
Q1 24
$-9.1M
$-6.3M
Gross Margin
IMDX
IMDX
UAVS
UAVS
Q4 25
42.5%
Q3 25
53.5%
38.5%
Q2 25
67.6%
55.7%
Q1 25
62.0%
58.5%
Q4 24
40.0%
40.6%
Q3 24
43.5%
49.7%
Q2 24
48.1%
45.8%
Q1 24
25.6%
50.2%
Operating Margin
IMDX
IMDX
UAVS
UAVS
Q4 25
-2057.5%
Q3 25
-4249.2%
-160.1%
Q2 25
-1900.0%
-49.3%
Q1 25
-318.0%
-27.5%
Q4 24
-2262.9%
-207.0%
Q3 24
-11752.2%
-56.7%
Q2 24
-4453.8%
-74.9%
Q1 24
-5265.3%
-61.5%
Net Margin
IMDX
IMDX
UAVS
UAVS
Q4 25
-2015.4%
Q3 25
-4174.6%
-132.7%
Q2 25
-1880.7%
-30.5%
Q1 25
-312.0%
193.5%
Q4 24
-2255.1%
-791.9%
Q3 24
-11733.0%
-105.3%
Q2 24
-4355.8%
-86.4%
Q1 24
-5186.9%
-162.2%
EPS (diluted)
IMDX
IMDX
UAVS
UAVS
Q4 25
$-0.75
Q3 25
$-0.34
$-0.09
Q2 25
$-0.30
$-0.32
Q1 25
$-0.26
$-0.09
Q4 24
$-2.19
$52.35
Q3 24
$-0.98
$-16.03
Q2 24
$-0.36
$-12.06
Q1 24
$-1.13
$-70.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMDX
IMDX
UAVS
UAVS
Cash + ST InvestmentsLiquidity on hand
$11.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$-31.5M
$28.3M
Total Assets
$25.8M
$34.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMDX
IMDX
UAVS
UAVS
Q4 25
$11.6M
Q3 25
$18.7M
Q2 25
$24.3M
Q1 25
$31.0M
$3.8M
Q4 24
$8.6M
$3.6M
Q3 24
$3.4M
$265.1K
Q2 24
$9.3M
$977.2K
Q1 24
$5.6M
$822.9K
Total Debt
IMDX
IMDX
UAVS
UAVS
Q4 25
Q3 25
Q2 25
Q1 25
$420.4K
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IMDX
IMDX
UAVS
UAVS
Q4 25
$-31.5M
Q3 25
$-9.2M
$28.3M
Q2 25
$1.1M
$16.3M
Q1 25
$10.2M
$4.2M
Q4 24
$-12.3M
$-5.7M
Q3 24
$9.7M
$6.2M
Q2 24
$22.7M
$8.1M
Q1 24
$11.6M
$9.1M
Total Assets
IMDX
IMDX
UAVS
UAVS
Q4 25
$25.8M
Q3 25
$43.9M
$34.5M
Q2 25
$50.5M
$23.2M
Q1 25
$60.4M
$20.2M
Q4 24
$35.1M
$20.6M
Q3 24
$70.2M
$22.0M
Q2 24
$74.7M
$22.8M
Q1 24
$71.0M
$23.2M
Debt / Equity
IMDX
IMDX
UAVS
UAVS
Q4 25
Q3 25
Q2 25
Q1 25
0.10×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMDX
IMDX
UAVS
UAVS
Operating Cash FlowLast quarter
$-5.5M
$-3.3M
Free Cash FlowOCF − Capex
$-7.0M
$-3.3M
FCF MarginFCF / Revenue
-616.7%
-168.0%
Capex IntensityCapex / Revenue
129.9%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.4M
$-9.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMDX
IMDX
UAVS
UAVS
Q4 25
$-5.5M
Q3 25
$-4.5M
$-3.3M
Q2 25
$-6.3M
$-2.7M
Q1 25
$-5.9M
$-1.3M
Q4 24
$-5.4M
$-2.5M
Q3 24
$-5.5M
$-1.1M
Q2 24
$-6.0M
$-1.4M
Q1 24
$-3.8M
$-1.6M
Free Cash Flow
IMDX
IMDX
UAVS
UAVS
Q4 25
$-7.0M
Q3 25
$-5.6M
$-3.3M
Q2 25
$-6.6M
$-2.8M
Q1 25
$-6.2M
$-1.3M
Q4 24
$-5.6M
$-2.5M
Q3 24
$-5.6M
$-1.1M
Q2 24
$-6.2M
$-1.4M
Q1 24
$-3.9M
$-1.6M
FCF Margin
IMDX
IMDX
UAVS
UAVS
Q4 25
-616.7%
Q3 25
-2135.4%
-168.0%
Q2 25
-1279.5%
-65.7%
Q1 25
-288.4%
-35.8%
Q4 24
-374.5%
-89.7%
Q3 24
-4884.3%
-32.7%
Q2 24
-5931.7%
-42.5%
Q1 24
-2189.8%
-40.5%
Capex Intensity
IMDX
IMDX
UAVS
UAVS
Q4 25
129.9%
Q3 25
403.8%
0.7%
Q2 25
67.4%
0.3%
Q1 25
14.4%
0.3%
Q4 24
14.4%
0.5%
Q3 24
75.7%
0.0%
Q2 24
183.7%
0.4%
Q1 24
13.6%
0.6%
Cash Conversion
IMDX
IMDX
UAVS
UAVS
Q4 25
Q3 25
Q2 25
Q1 25
-0.18×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMDX
IMDX

Segment breakdown not available.

UAVS
UAVS

Drones Segment$1.1M54%
Other$912.5K46%

Related Comparisons